Effect of Improving Volume Overload on Home Blood Pressure Variability in Hemodialysis Patients

Blood pressure variability is an independent predictor of adverse clinical events in hemodialysis patients. Volume overload is one of the most important factors affecting blood pressure homeostasis. In the present study, we explored the effects of dry weight reduction on home blood pressure variability in volume overload hemodialysis patients. Hemodialysis patients with volume overload had their dry weight gradually decreased under the guidance of bioimpedance methods, which was represented by calf‐bioimpedance ratio (Calf‐BR). Home blood pressure was measured on waking up and at bedtime for 1 week at baseline and at the end of the two‐month study. Coefficient of variation was used to define home blood pressure variability. Thirty‐eight hemodialysis patients had their dry weight significantly decreased from 60.7 ± 11.3 to 59.6 ± 10.7 kg (P = 0.003) accompanied with a significant reduction in calf‐BR (0.828 ± 0.023 vs. 0.786 ± 0.020, P<0.001). The systolic and diastolic blood pressure decreased significantly. Moreover, the whole‐day, morning, and evening systolic blood pressure variability gradually and significantly decreased by the end of the study (5.6 ± 2.1% versus 4.0 ± 1.7%, P<0.001; 7.7 ± 3.5% vs. 6.3 ± 2.7%, P = 0.005; 7.5 ± 2.8% vs. 5.9 ± 2.3%, P = 0.002, respectively). Diastolic blood pressure variability parameters were unchanged. The interdialytic weight gain and the incidence of adverse events were similar throughout the study period. Gradual dry weight reduction by bioimpedance methods improved home blood pressure variability in hemodialysis patients with chronic fluid overload.     

Effects of Sodium Concentration and Dialysate Temperature Changes on Blood Pressure in Hemodialysis Patients: A Randomized,Triple‐Blind Crossover Clinical Trial

The present study investigated the effects of different temperatures and sodium dialysate concentration on blood pressure in hemodialysis patients. Following Williams’ design, hemodialysis patients were randomly assigned into four dialysis modes. Dialysate temperature was set at 37°C for modes A and C and, 35°C for modes B and D. Sodium concentration was set at 138 mmol/L in modes A and B, while it changed from 150 mmol/L to 138 mmol/L in modes C and D. Using analysis of variance for repeated measures, the mean values of systolic and diastolic blood pressure were investigated. The mean values of systolic and diastolic blood pressure in modes C and D had a significant difference with the values in mode A. The mean values of systolic and diastolic blood pressure in patients dialyzed with mode B had a significant difference with the values in those dialyzed with mode D. Moreover, there were significant differences in the incidence of hypotension between A and other modes and between B and modes C and D, but this difference was not significant between modes C and D. In order to reduce intradialytic blood pressure fluctuations and hypotension, the nursing staff are recommended to gradually reduce dialysate sodium concentration.     

Perioperative Blood Pressure Variability in the Treated Hypertensive Patients

Perioperative blood pressure (BP) management is important to prevent cardiovascular complication, especially for hypertensive patients. In the present study, we investigated perioperative BP variability and contributing factors in hypertensive patients. Subjects were 28 treated hypertensive patients who underwent total or subtotal gastrectomy. Ambulatory BP monitoring was carried out before and after (16 days in average) the surgery. Angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and diuretics were withdrawn on the previous day, while other drugs were administered until the day of surgery. BP, body weight, blood chemistry, as well as the use of intravenous vasopressor or vasodepressor agents during the perioperative period were investigated. The 24-hour BP before surgery was 124 ± 19/70 ± 12 mm Hg, and the number of antihypertensive drugs was 1.8. In 22 patients, intravenous vasopressor agents were used during surgery, while another patient received intravenous vasodepressor agents after surgery. The 24-hour BP significantly decreased after surgery (?8.2 ± 14.7/?2.6 ± 7.3 mm Hg). Body weight, serum Na, and hematocrit also decreased. There were nine patients whose 24-hour systolic BP decreased by more than 10 mm Hg and for two patients more than 20 mm Hg. The decrease in BP correlated with the change in serum Na. Forty-three percent of the patients who took ACE inhibitors/ARBs showed BP reduction greater than 10 mm Hg, while 25% of the patients without these drugs showed such BP reduction. Our findings suggest that 24-hour BP decreases after gastrectomy. Patients taking ACE inhibitors or ARBs may need careful monitoring to prevent excessive BP fall.     

家庭自测血压的可靠性

目的通过对3种血压测量方法进行比较，为家庭自测血压用于临床和科研积累经验和科学数据。方法利用“代用盐对高血压患者及其家庭成员降压效果随机双盲对照试验研究”中收集的同一研究对象（n=220）不同方法获得血压（门诊血压、家庭自测血压和动态血压）测量数据，以动态血压数据作为参照，比较家庭血压及门诊血压与动态血压的一致性。干预前，217人3种血压测量方法数据均合格；干预结束时，189人3种血压测量方法数据均合格；将干预前和干预结束时测量合格的数据合并分析（n=406）。利用Bland-Altman对3种测量方法测得的血压水平进行组内一致性检验，并进行Person相关性分析；利用McNemar卡方检验比较3种方法的个体内一致率。结果门诊血压、动态血压和家庭自测血压3种方法测得的血压水平（收缩压／舒张压）分别为（149，5&#177;16．4）／（87．2&#177;9，5）、（137．8&#177;17．1）／（83．2&#177;10．3）和（138．O&#177;14，2）／（82．4&#177;9．3）mmHg。家庭血压与动态血压的相关性优于门诊血压与动态血压的相关性，相关系数（收缩压／舒张压）分别为（0.55／0.62）和（0.36／0.46）。以动态血压为参照，家庭自测血压水平与动态血压（收缩压／舒张压）差异无统计学意义（-0.2／-0.7mmHg，P〉0.05），而门诊血压水平显著高于动态血压水平（11．7／4．0mmHg，P〈0.05）；家庭自测血压的收缩压个体内差异显著优于门诊血压（≤｜5｜mmHg为28．3％vs16．5％，P〈0.05；≤｜10｜mmHg为49．7％vs33．5％，P〈0.05），舒张压个体差异略高于门诊血压，但差异无统计学意义（P〉0.05）。结论与动态血压测量值相比，家庭自测血压比门诊血压更准确。     

Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L

Selection of a lower dialysate calcium concentration (DCa) can reduce calcium burden and prevent vascular calcification in hemodialysis patients. However, decreased DCa can worsen mineral and bone disorders. This 1‐year retrospective observational study evaluated 121 hemodialysis patients at Fukuoka Renal Clinic who underwent conversion of DCa from 3.0 mEq/L to 2.75 mEq/L. The primary outcomes were changes in serum levels of calcium, phosphate, and parathyroid hormone (PTH). The effects of baseline serum calcium and PTH levels on changes in biochemical parameters were also determined. One year after DCa conversion, mean serum calcium level decreased, while serum phosphate, alkaline phosphatase, and PTH concentrations increased. The rate of achievement of target PTH was higher in patients with lower serum PTH level at baseline, while patients with higher baseline serum PTH level tended to exceed the upper limit of the PTH target range. Patients with higher baseline serum calcium concentration showed a greater decrease in serum calcium level and a greater increase in serum PTH level at 1 year. Patients with a lower baseline serum PTH level can benefit from optimal PTH control following conversion of DCa from 3.0 mEq/L to 2.75 mEq/L. However, secondary hyperparathyroidism may be exacerbated in some patients with higher baseline serum calcium (Ca) and PTH levels. These results indicate that an individualized approach can maximize the benefits of Ca unloading after conversion to lower DCa.     

Blood Pressure Measurements and Carotid Intima Media Thickness in Hemodialysis Patients

In hemodialysis (HD) patients, routine dialysis center blood pressure (BP) measurements may be a poor indicator of BP control. Ambulatory blood pressure monitoring (ABPM) improves the predictability of BP as a risk factor for target organ damage. Carotid intima‐media thickness (IMT) is an important indicator of asymptomatic atherosclerosis and a predictor of cardiovascular events. The purpose of our study was to evaluate the possible association between different BP measurements and carotid IMT in HD patients. Eighty‐five HD patients were included in our study. BP was measured with a standard mercury sphygmomanometer before and after each HD session. The average one‐monthly values of routine BP measurements were also analyzed. 24‐ and 48‐h ABPM was performed after the end of each HD session using non‐invasive ABPM. The average values of systolic and diastolic BP were analyzed separately for the first (HD) and second (interdialytic) days ABPM, and for both days together. Using B‐mode ultrasonography, carotid IMT was measured and plaque occurrence investigated. We found a statistically significant correlation between carotid IMT and the average one‐monthly pre‐HD diastolic BP (P < 0.05), diastolic BP on the HD‐day ABPM, the interdialytic‐day ABPM, and during 48‐h ABPM (P < 0.05). By multiple regression analysis, we found a statistically significant correlation only between carotid IMT and diastolic BP on the HD‐day ABPM, the interdialytic‐day ABPM, and during 48‐h ABPM (P < 0.05). Only longer BP measurements (24‐ and 48‐h ABPM) were associated with carotid IMT in HD patients.     

家庭血压监测的临床应用

血压测量是诊断高血压病的基本手段,目前主要有三种方法评价血压：诊所偶测血压、动态血压监测和家庭血压监测。家庭血压监测方便、经济,已有大量数据表明：与诊所偶测血压相比,家庭血压监测是评估心血管疾病风险的一个更好的预测因子。同时它能改善高血压患者的治疗依从性,有利于血压控制,监测降压药物疗效,减少医疗费用。另外对鉴别白大衣高血压和隐性高血压也很有帮助。     

高血压患者血压变异性的临床研究

目的探讨高血压病人血压变异性的特点。方法对４８例血压正常人和４２例高血压病人进行动态血压监测。结果无论是高血压组还是正常对照组血压变异性与血压均值一样白天增高，夜间下降，而且收缩压变异大于舒张压变异。但高血压组血压变异性各项指标均显著大于正常对照组（Ｐ＜０．０５）。结论高血压患者血压变异性明显高于血压正常者。     

Ambulatory Blood Pressure,Blood Pressure Variability and Antihypertensive Treatment

Ambulatory blood pressure monitoring is frequently employed in the clinical practice to improve the diagnosis of hypertension and the appropriateness of the decision regarding initiation of antihypertensive treatment. It is also frequently employed to check the efficacy of this treatment in conditions resembling daily life. This paper will describe the effect of a number of antihypertensive drugs on ambulatory blood pressure, based on data collected by our group in the past 10 years. It will then discuss the advantages of ambulatory blood pressure in studies on efficacy of antihypertensive drugs and the importance of this approach for definition of the trough-to-peak ratio of the antihypertensive effect. Some technical and clinical problems inherent to the ambulatory blood pressure monitoring approach will also be discussed.     

血压变异性与高血压靶器官损害的关系

目的探讨血压变异性与高血压靶器官损害的关系。方法选择６０例高血压病人进行２４ｈ动态血压监测和静息及应激状况下短时血压监测，以各时间段血压的标准差作为血压变异性指标，并测定左心室重量指数（ＬＶＭＩ）和２４ｈ尿微量蛋白（ＭＡＵ）。结果与正常对照组比较，高血压患者长时血压变异增大，静息及心算时的短时血压变异也增大；ＬＶＭＩ，ＭＡＵ与长时血压变异显著相关，但与各状态下短时血压变异不相关。结论提示血压变异性增大是高血压患者的一个重要的临床特征，长时血压变异可能与某些靶器官（心、肾）损害有关     

Home Blood Pressure Control After the Great East Japan Earthquake in Patients on Chronic Hemodialysis

At 14:46 on 11 March 2011, northeastern Japan was struck by a major earthquake measuring 9.0 on the Richter scale (the Great East Japan Earthquake). Several reports have suggested a transient blood pressure (BP) increase after a major earthquake, but its impact on BP in chronic dialysis patients has not been reported. In a retrospective review of 25 hemodialysis patients who were residents of Koriyama City, changes in the morning home BP after the earthquake were investigated. Home systolic and diastolic BPs were significantly elevated 1 week after the earthquake (158 ± 16 mm Hg vs. 151 ± 13 mm Hg, P < 0.01, for systolic; 81 ± 13 mm Hg vs. 78 ± 11 mm Hg, P = 0.01, for diastolic). Mean home BP 1 week after the earthquake was unchanged from baseline in patients treated with sympatholytics and/or renin‐angiotensin system (RAS) inhibitors. BP values returned to baseline by 4 weeks after the earthquake, but percent changes in mean BP were significantly greater even 2 weeks, 4 weeks, and 6 weeks after the earthquake in patients not treated with RAS inhibitors than in those treated with RAS inhibitors (2 weeks 7.0% ± 4.5% vs. 0.2% ± 5.0%, P < 0.01; 4 weeks 4.4% ± 5.9% vs. ?1.8% ± 5.3%, P = 0.02; 6 weeks 4.6% ± 4.9% vs. ?1.9% ± 3.9%, P < 0.01). On multiple regression analysis, RAS inhibitor use had an independent relationship with percentage increases in mean BP during the 6 weeks after the earthquake. Home BP was significantly increased after a major earthquake in patients on chronic hemodialysis. Prolonged deterioration of BP control after the earthquake was associated with non‐use of RAS inhibitors.     

Ambulatory Blood Pressure Variability Is Increased in Diabetic Hypertensives

The purpose of this study was to examine the possible difference in the 24-hr BP profile—including short-term BP variability, assessed as the standard deviation—between diabetic and non-diabetic hypertensives. We measured 24-hr ambulatory BP in 11 diabetic hypertensives (diabetic HT) and 10 non-diabetic hypertensives (non-diabetic HT) who were hospitalized for the educational program in our hospital and were under stable salt intake. Renal function and sleep apnea were also estimated. There were no significant differences in 24-hr systolic BP (141 mmHg vs. 135 mmHg, ns), daytime systolic BP (143 mmHg vs. 138 mmHg, ns), and nighttime systolic BP (135 mmHg vs. 130 mmHg, ns) between diabetic HT and non-diabetic HT. The values of 24‐hr HR (69.7 beats/min vs. 65.2 beats/min, ns) and 24-hr HR variability (9.9 beats/min vs. 10.1 beats/min, ns) were also similar between the groups. Interestingly, diabetic HT had a significantly greater 24-hr systolic and diastolic BP variability than non-diabetic HT (18.2 mmHg vs. 14.5 mmHg, p < 0.05; 11.5 mmHg vs. 9.6 mmHg, p < 0.05, respectively). The values for creatinine clearance, urinary protein excretion, and apnea-hypopnea index were similar between the groups. Bivariate linear regression analysis demonstrated that fasting blood glucose was the primary determinant of 24-hr diastolic BP variability (r = 0.661, p < 0.01). Multiple stepwise regression analysis revealed that fasting blood glucose was a significant and independent contributor to 24-hr systolic BP variability (r = 0.501, p < 0.05). Taken together, these results demonstrate that BP variability is increased in diabetic hypertensives. Furthermore, it is possible that an elevation of fasting blood glucose may contribute to the enhanced BP variability in hypertensives.     

伴及不伴OSA高血压患者的血压变异性和OSA相关性研究

目的研究伴或不伴睡眠呼吸暂停(obstructive sleep apnea,OSA)高血压患者的血压变异性和OSA的相关性。方法纳入阴虚阳亢型轻中度高血压患者90例,对患者行便携式睡眠仪监测、24h动态血压(ABPM)监测。观察患者血压的均值、变异性,及昼夜节律和OSA的关系;采用多元逐步回归法分析OSA和血压的关系。结果与不伴OSA的高血压患者相比,伴OSA患者的血压变异性和非杓型血压发生率明显增高,夜间血压下降率明显降低(P<0.05);其中夜间平均收缩压、24h收缩压血压标准差与睡眠呼吸暂停低通气指数(apnea hypopnea index,AHI)呈正相关,夜间收缩压下降率和AHI呈负相关(P<0.05)。结论伴OSA患者的血压变异性增高,昼夜节律紊乱。     

Weekly Variation of Home and Ambulatory Blood Pressure and Relation Between Arterial Stiffness and Blood Pressure Measurements in Community-Dwelling Hypertensives

Although blood pressure (BP) is a major determinant of pulse wave velocity (PWV), some treatments have independent effects on BP and arterial stiffness. Although both ambulatory BP (ABP) and self-measured BP at home (HBP) have become important measures for the diagnosis and management of hypertension, single day recordings may be insufficient for a proper diagnosis of hypertension or the evaluation of treatment efficacy. To evaluate weekly variations in BP using 7-day HBP and 7-day ABP monitoring and to determine the relation between arterial stiffness and BP measurements in community-dwelling patients with hypertension. We enrolled 68 community-dwelling hypertensive subjects in this study. Significant weekly variations in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were found in the awake ABP data (p < .01, respectively), while no significant weekly variations in the asleep ABP or the morning and evening HBP data were observed. In untreated subjects, significant correlations were obtained between the brachial-ankle PWV and the average awake SBP, the average asleep SBP and the average SBP measured by HBP in the evening. In treated subjects, only the average SBP measured by HBP in the morning was significantly correlated with the baPWV. Differences in the weekly variations in BP were observed between HBP and ABP monitoring. In addition, the morning systolic HBP was not correlated with arterial stiffness in untreated subjectswith hypertension but was correlated in treated subjects. Relations between the morning HBP and arterial stiffness might be attributed to morning surges in BP and/or trough levels of antihypertensive drugs.     

高血压合并阻塞性睡眠呼吸暂停低通气综合征患者短时血压变异性的影响因素研究

目的:探讨高血压合并阻塞性睡眠呼吸暂停低通气综合征(OSAS)患者短时血压变异性(BPV)的影响因素。方法:选择2017年6月至2019年5月在宁波市第一医院心血管科诊治的153例高血压患者,给予多导睡眠呼吸监测及动态血压监测,根据睡眠呼吸暂停低通气指数(AHI)将患者分四组:单纯高血压作为对照组(41例)、高血压合并轻度OSAS组(36例)、高血压合并中度OSAS组(36例)、高血压合并重度OSAS组(40例)。采用因子分析方法提取影响高血压合并OSAS患者短时血压变异性的公因子,进行多元线性回归分析影响高血压合并OSAS患者短时血压变异性的因素。结果:因子分析纳入可能影响高血压合并OSAS患者短时血压变异性的因素,共提取4个公因子:体重指数、OSAS严重程度相关参数、生活行为习惯、年龄及高血压病程;多元线性回归分析显示OSAS严重程度与高血压合并OSAS患者夜间收缩压短时血压变异性(nSBPARV)及夜间舒张压短时血压变异性(nDBPARV)均存在相关性(β=0.277,P<0.05;β=0.360,P<0.05),对于高血压合并OSAS患者nSBPARV的影响因素依次为OSAS严重程度>年龄及高血压病程(分别为β=0.277,P<0.05;β=0.225,P<0.05),对于nDBPARV的影响因素依次为OSAS严重程度>体重指数(分别为β=0.360,P<0.05;β=0.187,P<0.05)。高血压合并轻度、中度、重度OSAS组的nSBPARV、nDBPARV均较对照组大;且高血压合并重度OSAS组的nSBPARV、nDBPARV、日间收缩压短时血压变异性均大于对照组、高血压合并轻度、中度OSAS组,差异均具有统计学意义(P<0.05)。结论:高血压患者合并OSAS时容易出现夜间短时血压变异性增加,OSAS严重程度是高血压合并OSAS患者夜间血压短时变异性增加的主要因素,肥胖、年龄及高血压病程也是重要影响因素。     

血压变异的研究进展

血压变异是人类血压的最基本的生理特征之一。高血压患者血压变异异常,机制复杂。遗传与许多环境因素都影响血压变异。当前,对血压变异及高血压相关基因研究日益深入。血压变异和血压水平一样决定高血压患者靶器官的损害及总体预后。异常血压变异应尽早发现及恰当治疗。     

Associations Between Day-by-Day Variability in Blood Pressure Measured at Home and Antihypertensive Drugs: The J-HOME-Morning Study

We identified the factors associated with home blood pressure (BP) variability in 1933 patients treated with hypertensive drugs (mean age, 67 years; women, 55%). Multivariate regression analysis showed that female gender, advanced age, home BP value, and home heart rate variability were positively associated with home BP variability, whereas home heart rate, body mass index, and duration of antihypertensive treatment were negatively associated with home BP variability. Moreover, not being medicated with amlodipine and being medicated with angiotensin II receptor blockers were associated with increased home systolic BP variability only among patients who were treated for less than 12 months.     

Blood Pressure Variability and Hemodynamic Response to Stress in Patients with Paroxysmal Elevation of Blood Pressure

Blood pressure variability during 24 hours and hemodynamic response to stress were studied in essential hypertensive patients, displaying paroxysmal hypertension and pheochromocytoma-type symptoms (PH). Hemodynamics at rest, in response to mental arithmetic, bicycle ergometer exercise or the cold together with baroreflex sensitivity were not different between these patients and other essential hypertensives (EH). Average waking systolic blood pressure was lower but variabilities of both systolic and diastolic blood pressure were greater in PH than in EH. During sleep, these differences disappeared. Thus, the greater variability in blood pressure seen only in waking PH patients cannot be estimated from the hemodynamic patterns at rest and is not likely to be related to an excessive response to stress or impaired baroreflex.     

血压变异性与心房颤动相关性研究

［］ 目的 探讨血压变异性(BPV)对心房颤动发生及左心结构的影响。方法 随机选取我科2013年6月至2015年10月就诊患者120例患者,其中永久性房颤40例,持续性房颤40例,阵发性房颤40例,选取同期住院的窦性心律患者40例,测24h动态心电图、动态血压、超声心动图对160例患者检测,比较四组患者血压变异性及左房内径。 结果 心房颤动组的血压变异性、左房内径较正常对照组明显增加,房颤组内比较,永久性房颤组较持续性房颤组、阵发性房颤组血压变异性明显增大。 结论 心房颤动的患者血压变异性明显增加,且心房颤动的严重程度与血压变异性呈正相关。#$NL［关键词］心房颤动;血压变异性;左房内径     

One‐Year Impact of Kidney Transplantation on Cardiac Abnormalities and Blood Pressure in Hemodialysis Patients

Cardiac abnormalities, including left ventricular hypertrophy and systolic dysfunction, are frequently observed among patients with CKD, including kidney transplant recipients; they are closely linked to cardiovascular disease and mortality. Although several studies have been performed for elucidating changes and mechanisms of cardiac abnormalities after kidney transplantation, details remain unclear. This study included 43 consecutive patients who underwent HD and received kidney transplantation between 2008 and 2012 at our institution. All subjects underwent echocardiography before and 1 year after kidney transplantation. One year after kidney transplantation, left ventricular mass index, cardiac chamber sizes, BP, and the number of antihypertensive agents were reduced. Although the percentage of patients with concentric hypertrophy did not change, the percentage of those with eccentric hypertrophy significantly decreased after kidney transplantation. Volume reduction due to the recovery of kidney function may be primarily attributed to the improvement of cardiac abnormalities, including left ventricular hypertrophy.